The Clinical Research Operations and Management Branch (CROMB) has responsibility for assessing study risk, implementing data and safety monitoring oversight, tracking enrollment progress, and mitigating study related issues for the complete portfolio of NIAMS funded clinical trials and select human subjects observational studies with some level of risk (60-70 studies currently active in the managed portfolio). Specifically, this responsibility includes:

The Division of Extramural Activities (DEA) serves as a critical resource for our Extramural Programs, responsible for the areas of overall administration and management, scientific review, grants management, and clinical research administration. As a partner in the NIAMS mission, we promote the quality and impact of scientific research by assuring compliance with NIH and NIAMS policies and procedures in a transparent, consistent, fair and ethical manner. Specifically, the DEA: